This Month in Psychopharmacology

THIS MONTH IN
PSYCHOPHARMACOLOGY

Browsing articles in "Psychotic Disorders"

Review: Benefits vs. Risks of Aripiprazole During Pregnancy
February 7, 2018

A systematic literature search and review evaluated the available data on the use of aripiprazole during pregnancy, peripartum and lactation...

Continue reading (Members only)

FDA Approves Pill That Digitally Tracks Adherence
November 13, 2017

The US Food and Drug Administration (FDA), recently approved the first drug in the U.S. with a digital ingestion tracking system...

Antipsychotic Use in Intellectually Disabled Adults
September 1, 2017

Antipsychotic medication is frequently being prescribed to individuals with intellectual and developmental disabilities (IDD), often without a psychiatric diagnosis...

Deutetrabenazine Approved to Treat Tardive Dyskinesia
August 30, 2017

The U.S. Food and Drug Administration (FDA) has approved deutetrabenazine, trade name Austedo, for the treatment of tardive dyskinesia...

Non-Dopaminergic Drug Shows Efficacy in Reducing Negative Symptoms of Schizophrenia
August 13, 2017

A recent study examined the efficacy, safety, and tolerability of the compound, MIN-101 compared to placebo in patients with schizophrenia...

Continue reading (Members only)

Cannabis Use, Medication Non-Adherence, and Psychosis Relapse
August 4, 2017

New research shows that cannabis use by patients with psychosis is linked to a significantly increased risk for psychosis relapse. That increase in risk for relapse may be directly due to non-adherence to antipsychotic medication...

Continue reading (Members only)

Adverse Events and Limited Efficacy for Antipsychotics in Pediatric Psychosis
July 14, 2017

The treatment of psychosis in children and adolescents is perhaps more complicated and certainly less studied compared to psychosis in the adult population...

Continue reading (Members only)

What's New in Tardive Dyskinesia?
June 30, 2017

Tardive dyskinesia was the focus of several sessions, lectures, and posters at the recent 2017 American Psychiatric Association (APA) Annual Meeting...

Continue reading (Members only)

Recall: Paliperidone Extended-Release Tablets
June 16, 2017

Teva Pharmaceuticals has issued a voluntary recall of a single lot of paliperidone extended-release tablets...

Continue reading (Members only)

Highlights from the 2017 APA Annual Meeting
June 8, 2017

The 2017 APA annual meeting, held in NEI's hometown of San Diego, was themed "Prevention Through Partnership" and included more than 400 sessions. Here, we provide highlights of the meeting, including NEI's podcast interviews with expert presenters, key research from the poster sessions, and NEI's debut live concert--the NEI PsychopharmaJam.

Top of Page